These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4276506

  • 1. Proceedings: Eosinophilia during gold therapy.
    Jessop JD, Dippy J, Turnbull A, Bright M.
    Rheumatol Rehabil; 1974 May; 13(2):75-80. PubMed ID: 4276506
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L, Hinojosa W, Chincaro C, Portugal J, Barrenechea O.
    Rev Clin Esp; 1974 May; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract] [Full Text] [Related]

  • 3. Gold therapy in rheumatoid arthritis.
    Schorn D, Anderson IF.
    S Afr Med J; 1975 Aug 30; 49(37):1505-6. PubMed ID: 125934
    [Abstract] [Full Text] [Related]

  • 4. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients.
    Lockie LM, Smith DM.
    Semin Arthritis Rheum; 1985 May 30; 14(4):238-46. PubMed ID: 2934818
    [No Abstract] [Full Text] [Related]

  • 5. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.
    Kean WF, Anastassiades TP.
    Arthritis Rheum; 1979 May 30; 22(5):495-501. PubMed ID: 156026
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J, Davis P, Owen ET.
    J Rheumatol; 1983 Feb 30; 10(1):121-3. PubMed ID: 6405032
    [Abstract] [Full Text] [Related]

  • 7. Myelotoxicity of gold.
    Kay AG.
    Br Med J; 1976 May 22; 1(6020):1266-8. PubMed ID: 817772
    [Abstract] [Full Text] [Related]

  • 8. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF, Lock CJ, Howard-Lock HE, Buchanan WW.
    Arthritis Rheum; 1982 Aug 22; 25(8):917-22. PubMed ID: 6214261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter.
    J Rheumatol; 1975 Mar 22; 2(1):21-7. PubMed ID: 127042
    [Abstract] [Full Text] [Related]

  • 12. Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. A prospective investigation.
    de Bosset PL, Biter T.
    Schweiz Med Wochenschr; 1973 Aug 18; 103(33):1153-8. PubMed ID: 4201618
    [No Abstract] [Full Text] [Related]

  • 13. Response of rheumatoid arthritis with leukopenia to gold salts.
    Gowans JD, Salami M.
    N Engl J Med; 1973 May 10; 288(19):1007-8. PubMed ID: 4633144
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)].
    Slobodina GA.
    Ter Arkh; 1985 May 10; 57(7):131-6. PubMed ID: 2931846
    [Abstract] [Full Text] [Related]

  • 15. Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate.
    Palmer DG, Dunckley JV.
    Aust N Z J Med; 1973 Oct 10; 3(5):461-6. PubMed ID: 4204711
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR, Ström H, Bjelle A, Möller E.
    Clin Rheumatol; 1985 Mar 10; 4(1):55-61. PubMed ID: 3157529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.